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The enteric pathogen enterohemorrhagic Escheri-
chia coli (EHEC) causes severe diarrhea, but the
influence of the gut microbiota on EHEC infection
is largely unknown. A predominant member of the
microbiota, Bacteroides thetaiotaomicron (Bt), is re-
sident at EHEC attachment sites. We show that Bt
enhances EHEC virulence gene expression through
the transcription factor Cra, which is functionally
sensitive to sugar concentrations. This enhanced
virulence accompanies increased formation of at-
taching and effacing (AE) lesions requisite for EHEC
colonization. Infection with Citrobacter rodentium,
a natural mouse pathogen homologous to EHEC,
in Bt-reconstituted mice results in increased gut
permeability along with exacerbated host pathology
and mortality compared to mice deplete of micro-
flora. Bt modifies the metabolite environment at
infection sites, increasing metabolites involved in
gluconeogenesis, with stark increases in succinate,
which can be sensed by Cra. Our findings suggest
that microbiota composition affects disease out-
come and may explain links between microbiota
composition and disease susceptibility.
INTRODUCTION
Trillions of commensal bacteria inhabit the gastrointestinal tract,
with the highest diversity and abundance of microbial species
residing within the colon (Walter and Ley, 2011). The gut micro-
biota contribute to gut maturation, host nutrition, and pathogen
resistance (Hooper et al., 2002; Sommer and Ba¨ckhed, 2013),
but recent findings also implicate a role for the microbiota in in-
flammatory bowel disease (IBD), cancer, obesity, diabetes, and
heart disease (Honda and Littman, 2012; Spor et al., 2011). Mul-
tiple studies indicate that differences in microbial composition
exist between healthy and diseased patients; however, it is not
well understood if these shifts occur prior to disease or are aCell Host &product of the disease (Gevers et al., 2014; Larsen et al., 2010;
Peterson et al., 2008; Turnbaugh et al., 2009a; Turnbaugh
et al., 2009b; Wang et al., 2009).
Transplantation of the microbiota frommouse strains resistant
to Citrobacter rodentium infection rescued susceptible mice
from a lethal challenge with C. rodentium, demonstrating that
resistance could be transferred and that microbial compositions
affect disease susceptibility (Willing et al., 2011). Additionally,
successful treatment of recurrent Clostridium difficile infection
through fecal transplantation further demonstrates that a ba-
lanced microbiota play an important role in preventing dysbiosis
(Borody and Khoruts, 2012; Kelly et al., 2014). Specific taxa
have been associated with increased disease susceptibility. A
prospective study of the gut microbiota compositions in poultry
workers before, during, and after exposure to Campylobacter
found that those infected had elevated proportions of Bacter-
oides and Escherichia compared to those that remained unin-
fected despite repeated exposure (Dicksved et al., 2014).
A member of the Bacteroidetes phylum and major constituent
of themicrobiota,Bacteroides thetaiotaomicron encodes a num-
ber of glycoside hydrolases and polysaccharide lyases that
enrich the availability of nutrients within the intestine (Son-
nenburg et al., 2005). Within the intestine, Bt degrades complex
polysaccharides into monosaccharides that can readily be used
by nonglycophagic bacterial species such as E. coli and
C. rodentium (Sonnenburg et al., 2005; Xu et al., 2003). Fluctua-
tions in sugar concentrations modulate virulence gene expres-
sion and colonization of the human pathogen Enterohemorrhagic
E. coli (EHEC) (Njoroge and Sperandio, 2012; Njoroge et al.,
2012; Pacheco et al., 2012). EHEC colonizes the human colon,
forming attaching and effacing (AE) lesions, invoking bloody
diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome
(HUS). AE lesions result from extensive remodeling of the host
cellular cytoskeleton that create a pedestal, or cup-like structure,
beneath the bacteria (Kaper et al., 2004). EHEC also encodes a
potent Shiga toxin (Stx) that is responsible for HUS (Kaper
et al., 2004). EHEC intestinal colonization is dependent on the
locus of enterocyte effacement (LEE) pathogenicity island (PAI)
(Kaper et al., 2004). The LEE region contains five major operons
(LEE1–5) that encode a type III secretion system (T3SS), an
adhesin (intimin) and its receptor (Tir), and effector proteins
(Kaper et al., 2004; Knutton et al., 1989). The ler gene encodedMicrobe 16, 759–769, December 10, 2014 ª2014 Elsevier Inc. 759
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Gut Microbiota Increase EHEC Virulencewithin LEE1 acts as themaster regulator of the LEE genes (Kaper
et al., 2004). Glycolytic conditions, such as those found in the gut
lumen, inhibit LEE1 expression while gluconeogenic conditions,
akin to those found near the epithelial surface, activate LEE1
expression (Njoroge and Sperandio, 2012; Njoroge et al., 2012;
Pacheco et al., 2012). We sought to understand if the metabolic
changes induced by Bt affect susceptibility to infection and dis-
ease progression of EHEC.
Our results demonstrate that Bt increases virulence gene
expression of EHEC and C. rodentium in vitro and during murine
infection, respectively, and that Bt regulation of EHEC virulence
occurs through the transcription factor Cra by sensing fluctua-
tions in sugar concentrations. Mice reconstituted with Bt
following antibiotics treatment lost weight and succumbed to
infection more rapidly than mice deplete of microflora. Perturba-
tions to a functional T3SS or to the presence of Shiga toxin atten-
uated disease progression, indicating that both a functional
T3SS and Shiga toxin contribute to disease. Bt reconstitution
augments the pathophysiology associated with C. rodentium
infection, enhancing edema of the colonic epithelium, exacer-
bating crypt destruction, increasing immune infiltration, and im-
pairing intestinal epithelial repair. Additionally, we identified
metabolites at sites of infection specific to Bt colonization,
C. rodentium infection, or a combination of Bt colonization and
C. rodentium infection. The metabolites are primarily involved
in oxidative stress, nucleotide synthesis, and gluconeogenesis.
Furthermore, we linked succinate, a metabolite increased at
the site of infection when Bt is present and that has previously
been shown to act as a virulence factor (Rotstein et al., 1985;
Rotstein et al., 1989), with augmented secretion of the EHEC
T3SS translocon. Together, our findings indicate that a promi-
nent member of themicrobiota enhances virulence gene expres-
sion of an enteric pathogen and worsens the prognosis of an
enteric infection.
RESULTS
Bt Increases Expression of One-Fifth of the E. coli
Array Probe Sets
To determine the global impact of Bt on EHEC gene expression,
we performed a microarray from EHEC cultures grown in the
presence or absence of Bt using the GeneChip E. coli Genome
2.0 array. The GeneChip E. coli Genome 2.0 array includes
approximately 10,000 probe sets for all genes present in the
following four strains of E. coli: K-12 lab strain MG1655, uropa-
thogenic strain CFT073, O157:H7 enterohemorrhagic strain
EDL933, and O157:H7 enterohemorrhagic strain Sakai. The mi-
croarray data represent a single replicate from each condition;
therefore, no statistical analysis or multiple hypotheses testing
correction was performed. Expression of one-fifth of the array
probe sets increased when EHEC was cultured with Bt (Fig-
ure 1A). The affected genes reflect an increase in competition
for nutrients, with 47% of the increased genes participating in
metabolism, 8% in amino acid regulation, and 9% in cellular
transport (Figure 1B). Expression of less than 1% of the EHEC
genome decreased, with the most affected genes playing a
role in purine and pyrimidine metabolism (Figure 1C). Despite
the increase in metabolic genes, EHEC displayed no growth
advantage when cultured with Bt (Figure 1D). However, EHEC760 Cell Host & Microbe 16, 759–769, December 10, 2014 ª2014 Elsprovided a distinct growth advantage to Bt, increasing Bt gener-
ation time from 282 min/gen when grown alone to 97 min/gen
when grown with EHEC (Figure 1E).
Bt Augments EHEC Virulence via the Catabolite
Repressor/Activator Protein
Expression of a myriad of EHEC virulence genes is increased in
the presence of Bt, including the LEE, stx2a (encoding Stx), and
stcE (encoding a mucinase) genes (Figure 2A). The LEE PAI con-
sists of 41 genes organized into five major operons (Kaper et al.,
2004). Transcription of all LEE operons is increased when EHEC
is cultured in the presence ofBt. In the presence ofBt, themaster
regulator of the LEE, ler, increased more than 3-fold (p < 0.001).
Transcription of the T3SS structural components escC and escV
increased approximately 4-fold and 3-fold, respectively (escC:
p < 0.0003; escV: p = 0.0319) in the presence of Bt while the
translocated intimin receptor tir increased 3-fold (p = 0.0021)
and the T3SS filament espA increased 2-fold (p = 0.05) (Fig-
ure 2A). In accordance, AE lesion formation in EHEC significantly
increased in the presence of Bt. In the presence of Bt, AE lesion
formation on HeLa cells increased from 23% to 54% (p <
0.0001), with an increase of 8.5 pedestals per infected cell in
the presence of Bt compared to 4.6 pedestals per cell in the
absence of Bt (Figures 2B–2D).
To determine the pathway through which Bt regulates EHEC,
we analyzed virulence gene expression in a panel of EHEC mu-
tants grown in the presence or absence of Bt. In the presence of
Bt, ler expression increased more than 3-fold in wild-type (WT)
EHEC. Similarly, in the qseC, qseE, and kdpE EHEC mutants,
ler expression increased approximately 3- to 4-fold when the
mutants were cultured in the presence of Bt. In contrast, no
enhancement of ler expression occurred in the cra EHECmutant,
demonstrating that Bt regulation of the LEE occurs through Cra,
a transcription factor that positively regulates EHEC virulence by
sensing fluctuations in sugar concentrations indicative of a glu-
coneogenic environment (Njoroge et al., 2013). Bt regulation
does not occur through the histidine sensor kinases QseC,
QseE, or FusK or through the response regulator KdpE that
play other important signaling roles in EHEC virulence gene
expression (Njoroge et al., 2013; Pacheco et al., 2012; Reading
et al., 2007; Sperandio et al., 2002) (Figures 2E and 2F). Fluctu-
ations in the concentrations of carbon metabolites are a major
mechanism to modulate virulence gene expression and coloni-
zation of EHEC (Njoroge et al., 2013; Pacheco et al., 2012). Anal-
ysis of our microarray data corresponds with Bt regulation of
EHEC gene expression through Cra (Figure S1 available online)
(Chin et al., 1989; Feldheim et al., 1990; Saier and Ramseier,
1996).
To determine if augmentation of the LEE extends beyond Bt
to other members of the intestinal microflora, we cultured
EHEC in the presence of Enterococcus faecalis, a prominent
member of the Firmicutes phyla. In the presence of E. faecalis,
an opportunistic Firmicutes, transcription of all LEE operons
was significantly increased (Figure 3). Transcription of ler
increased 19-fold (p < 0.0001), and escC, escV, and tir increased
7- to 10-fold in the presence of Bt (escC: p < 0.0001, escV: p <
0.0001, tir: p < 0.0001), indicating that members of the twomajor
intestinal microbiota phyla, Bacteroidetes and Firmicutes,
induce the LEE in EHEC.evier Inc.
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Figure 1. B. thetaiotaomicron (Bt) Increases Expression of One-Fifth of the E. coli Array Probe Sets
(A) Summary of microarray results comparing EHEC grown with Bt to EHEC grown alone (EHEC+Bt/EHEC only).
(B and C) Pie graph categorizing the E. coli genes by function (B), that increasedR 4-fold or (C), that decreasedR 2-fold in the presence of Bt.
(D and E) Growth curves (of six biological samples, experiments were repeated two times, eachwith three independent biological samples) of in vitro growth of (D)
EHEC or (E) Bt. The error bars indicate the SD of the mean. Doubling time for EHEC grown alone and in the presence of Bt is 50 min/gen and 53 min/gen,
respectively. Doubling time for Bt grown alone and in the presence of EHEC is 282 min/gen and 97 min/gen, respectively.
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Gut Microbiota Increase EHEC VirulenceC. rodentium as an Infection Model
EHEC is a natural human pathogen; however, EHEC poorly in-
fects mice, and mice do not develop key features of the disease
such as AE lesions, intestinal damage, and systemic illness (Mal-
lick et al., 2012; Mundy et al., 2005). To study the characteristics
of EHEC infection, we employed an infection model using a Stx-
producingC. rodentium strain (DBS770) constructed by Schauer
and colleagues (Mallick et al., 2012). Mice infected with this
strain develop AE lesions on the intestinal epithelium and Stx-
dependent damage to the intestinal epithelium and kidneys (Mal-
lick et al., 2012). In vitro analysis confirmed that Bt affects
C. rodentium in a similar manner to EHEC. Similarly to EHEC,
C. rodentium growth was unaffected by the presence ofBt; how-
ever, Bt generation time increased from 282 min/gen when
grown alone to 91 min/gen when grown with C. rodentium (Fig-
ures 4A and 4B).
Transcription of key LEE (ler, espA, eae) and non-LEE encoded
(nleA and stx2d) virulence genes was also increased when
C. rodentium was grown in the presence of Bt (Figure 4C).Cell Host &Expression of ler increased 6-fold in the presence of Bt (p =
0.0012). Expression of eae, the gene that encodes the adhesin
intimin essential for AE lesion formation, increased 5-fold (p =
0.0303), and the gene encoding the T3SS filament espA in-
creased by 7.5-fold (p = 0.0054). Bt impacted C. rodentium
growth and virulence in a similar manner to EHEC, augmenting
the virulence of these AE lesion pathogens in vitro. We reasoned
that C. rodentium would be a suitable model to study EHEC
infection in the context of an altered microflora.
Bt Mediates Its Provirulence Effect on C. rodentium by
Enhancing Expression of the T3SS, Not by a Bloom in the
C. rodentium Population
To determine the role of Bt duringC. rodentium infection in mice,
mice were depleted of their microflora (Kuss et al., 2011) and
then either left deplete of gut microflora or reconstituted with
Bt (Figure S2). The mice were then challenged with a WT
C. rodentium DBS100 strain, C. rodentium strain DBS770 that
is Shiga toxin (Stx)+, a DBS770 Stx (Dstx), a T3SS-deficientMicrobe 16, 759–769, December 10, 2014 ª2014 Elsevier Inc. 761
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Figure 2. Bt Augments EHEC Virulence via the Catabolite Repressor/Activator Protein
(A) qRT-PCR of LEE, stcE, and stx2A genes in EHEC grown alone ()Bt or in the presence ofBt (+) Bt (n = 9; error bars, SD; ***p < 0.001, **p < 0.01, and *p < 0.05).
(B) Fluorescent actin staining assay of HeLa cells infected with EHEC alone or in the presence of Bt, stained with FITC-phalloidin (actin, green) and propidium
iodide (bacterial and HeLa DNA, red). Original magnification, 633.
(C) Quantification of fluorescent actin staining assay of the percentage of HeLa cells infected, as defined by pedestal formation by EHEC.
(D) Number of pedestals/infected cell. (n = 350 cells; error bars, SD; ***p < 0.001.)
(E) qRT-PCR of ler in WT, DqseC, DqseE, Dcra, DkdpE, DDcrakdpE, and DfusK grown alone or in the presence of Bt (n = 9–15; error bars, SD; ***p < 0.001, **p <
0.01, and p > 0.05 equal not significant). Each mutant has been normalized to 1 to show the fold-increase of the mutant when grown in the presence of Bt (+) Bt.
(F) Representation of LEE PAI regulation.
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Gut Microbiota Increase EHEC Virulence(DescN), or a Cra-deficient (Dcra) C. rodentium (Figures S3
and 4). Bt-reconstituted mice lost weight and succumbed to
C. rodentium infection more rapidly than microflora-deplete
groups. C. rodentium-infected mice reconstituted with Bt began
to lose weight on day 4 postinfection. In contrast, C. rodentium-
infected mice deplete of microflora did not begin to lose weight
until day 6 postinfection (Figure 5A). By day 6 postinfection, 50%
of the C. rodentium-infected mice reconstituted with Bt had
succumbed to infection, whereas only 14% of the C. roden-
tium-infected mice deplete of microflora had died by day 6 post-
infection. Similarly, mice infected with C. rodentiumDstx and
reconstituted with Bt had 100% mortality by day 11 postinfec-
tion, while mice infected with C. rodentiumDstx but deplete of
microflora had 43%mortality on day 11 postinfection (Figure 5B).
The presence of Stx compounded these effects, demonstrating
that both the presence of Bt and the production of Stx contribute
to the morbidity and mortality during C. rodentium infection. It is
noteworthy that theDstxDBS770mutant behaves similarly to the
WTDBS100 strain (which does not encode Stx) in the absence or762 Cell Host & Microbe 16, 759–769, December 10, 2014 ª2014 Elspresence of Bt (Figures S3 and 5). However, this effect is lost if
C. rodentium is unable to form a functional T3SS and colonize
(Figures 5A and 5B). The cra mutant, as expected, is also atten-
uated for infection (Figure S4), highlighting the importance of
fluctuations of carbon metabolites during infection.
In Bt-reconstituted mice, C. rodentium virulence gene ex-
pression was increased compared to C. rodentium from micro-
flora-deplete mice (Figures 5C and S5A). Analysis of the major
phylogenetic groups determined that Bacteroidetes dominated
the Bt-reconstituted groups on days 1 and 4 postinfection, while
Proteobacteria dominated the microflora-deplete groups in-
fected with C. rodentium. Maintenance of Proteobacteria was
independent of Stx but dependent on a functional T3SS (Fig-
ure 5E). However, the bacterial burden of C. rodentium did not
significantly differ in mice reconstituted with Bt and then chal-
lenged with C. rodentium compared to those not reconstituted
with Bt (Figure S5B). Furthermore, examination of the ultrastruc-
ture of the distal colon showed destruction to the microvilli and
attachment of C. rodentium to the epithelium (Figure 5D). Theevier Inc.
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Figure 4. C. rodentium as an EHEC Infection Model
(A and B) Growth curves (of six biological samples, experiments were repeated
two times, eachwith three independent biological samples) of in vitro growth of
(A)C. rodentium or (B) Bt. The error bars indicate the SD of the mean. Doubling
time for C. rodentium grown alone and in the presence of Bt is 69 min/gen and
66min/gen, respectively. Doubling time forBt grown alone and in the presence
of C. rodentium is 282 min/gen and 91 min/gen, respectively.
(C) qRT-PCR of LEE, nleA, and stx genes inC. rodentium grown alone () Bt or
in the presence of Bt (+) Bt (n = 6; error bars, SD; **p < 0.01, *p < 0.05).
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Figure 3. E. faecalis, a Member of the Firmicutes Phylum, Augments
EHEC Virulence Gene Expression
qRT-PCR of LEE genes in EHEC grown alone () E. faecalis or in the presence
of (+) E. faecalis (n = 9; error bars, SD; ***p < 0.001).
Cell Host & Microbe
Gut Microbiota Increase EHEC Virulencepresence of Bt during C. rodentium infection does not cause a
bloom in the C. rodentium population, but rather an increase in
its virulence, akin to our observations in vitro (Figure 4).
Bt Contributes to the Accelerated Loss of a Protective
Mucosal Layer during C. rodentium Infection
To determine if the increased morbidity and mortality that
occurred during C. rodentium infection in Bt-reconstituted
mice was due to increased host pathology, we evaluated the
cecum and the colon for the following parameters: edema, crypt
integrity, neutrophil infiltration, apoptosis, bacterial attachment,
and vasculitis. The evaluation, performed in a double-blind
fashion, demonstrated that host pathology was worsened in
Bt-reconstituted mice, with augmented edema, vasculitis, apo-
ptosis, and destruction of the crypts (Figure 6A, 6B, and S6).
We also examined expression of host genes key in epithelial
repair and in innate defense. Within the gastrointestinal tract,
the mucus layer is the first line of defense against pathogens.
The colon consists of two mucus layers—an outer layer that
serves as a home to commensal bacteria and a tight inner layer
devoid of bacteria (Johansson et al., 2013). In mice deficient in
Muc2, the primary component of the colonic mucus layer, infec-
tion with C. rodentium causes rapid weight loss and mortality
and increased gut permeability compared to WT mice (Berg-
strom et al., 2010). Reconstitution with Bt during C. rodentium
infection augmented the loss of Muc2 (Figure 6C). Transcription
of intestinal trefoil factor 3 (Tff3), a secreted molecule important
in epithelial repair and maintenance of the mucosa (Taupin and
Podolsky, 2003), and Muc2 (Muc2) were significantly reduced
during C. rodentium infection in Bt-reconstituted mice (Tff3:
p = 0.0283;Muc2: p = 0.0148) (Figures 6D and 6E). Additionally,
expression of the bacterial serine protease p1411, a homolog of
Pic mucinase found in Shigella spp. and enteroaggregative
E. coli, increased in Bt-reconstituted animals compared to
mice deplete of microflora (Figure 6F). Consistent with the wors-
ened damage to the crypts and mucosa, gut permeability
increased in Bt-reconstituted mice during C. rodentium infection
(Figure 6G). Host pathology is worsened during C. rodentium
infection in Bt-reconstituted mice and likely contributes to theCell Host &increased morbidity and mortality in these mice. Conversely,
transcription of the innate defense genes Reg3b and Reg3g
were increased during C. rodentium infection and augmented
when Bt was also present (Figure S7). Of note, expression of
RegIIIg is increased in germ-free mice upon exposure to the mi-
crobiota, and this lectin kills only Gram-positive, but not Gram-
negative, bacteria such as Bt and C. rodentium (Cash et al.,
2006).
To further explore the mechanism of how Bt may be exerting
its provirulence effect on C. rodentium, we examined metabo-
lites present in the large intestine during infection. Our metabo-
lomics studies showed that the metabolic landscape between
mice colonized with Bt or not (PBS or C. rodentium infected
animals) were quite diverse and that the Bt alone and Bt +
C. rodentium animals have a more similar metabolite profile in
their intestines (Figures 7A and 7B). Of note, several metabolites
indicative of a gluconeogenic environment (such as lactate,Microbe 16, 759–769, December 10, 2014 ª2014 Elsevier Inc. 763
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Figure 5. Bt Mediates Its Provirulence Effect on C. rodentium by Enhancing Expression of the T3SS, Not by a Bloom in the C. rodentium
Population
C3H/HeJ mice were treated for 5 days with an antibiotics regimen to deplete gut microbiota. Half of the mice were reconstituted with Bt (+Bt) while the remainder
of the mice were left deplete of gut microbiota. Mice were mock infected (PBS, Bt only) or infected with C. rodentium (Citro, Stx+), C. rodentiumDstx (CitroDstx,
Stx-), or C. rodentiumDescN (CitroDescN).
(A) Weight loss or gain from baseline (weight at day 0) over the course of infection (blue: mock-infected, reconstituted with Bt; red: Citro-infected, deplete of
microbiota; green: Citro-infected, reconstituted with Bt; purple: CitroDstx-infected, deplete of microbiota; turquoise: CitroDstx-infected, reconstituted with Bt;
orange: CitroDescN-infected, deplete of microbiota; light blue: CitroDescN-infected, reconstituted with Bt).
(B) Survival after infection (n = 7–22mice/group; error bars, SD; ***p < 0.001, **p < 0.01: comparison ofCitro versusCitro+Bt; ##p < 0.01, #p < 0.05: comparison of
CitroDstx versus CitroDstx+Bt; +++p < 0.001, 2+p < 0.01: comparison of Citro+Bt versus CitroDstx+Bt).
(C) qRT-PCR analysis of ler, espA, eae, and nleA frommRNA isolated from fecal pellets of infected animals. Significance is indicated as follows: *pG 0.05, **pG
0.01, and ***pG 0.001.
(D) Ultrastructure of the distal colon harvested 5 days postinfection frommock-infected (PBS,Bt) orC. rodentium-infectedmice either deplete of gutmicrobiota or
reconstituted with Bt, 2,5003. Microvilli destruction and C. rodentium forming AE lesions on the colonic epithelium can be observed. Original magnification,
2,5003 (TEM).
(E) qRT-PCR of 16 S rRNA from the major phylogenetic groups (green: Proteobacteria, blue: Bacteroidetes, and purple: Firmicutes) from feces collected on day 1
and day 4 postinfection.
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Gut Microbiota Increase EHEC Virulencesuccinate, glycerate, and others) were elevated in the Bt-treated
animals (Figures 7A and 7B). Elevated concentrations of succi-
nate, but not of fumarate or pyruvate, were measured within
the cecumwhenBtwas present (Figure 7C), consistent with find-
ings identifying succinate as a major metabolic by-product of
Bacteroides spp (Macy et al., 1978). Succinate produced by
Bacteroides spp. has been shown previously to impair neutrophil
function and inhibit phagocytic killing of E. coli (Rotstein et al.,
1985, 1989). Additionally, in a recent complementary study, Son-764 Cell Host & Microbe 16, 759–769, December 10, 2014 ª2014 Elsnenburg and colleagues demonstrated that microbiota-pro-
duced succinate induced after antibiotic treatment augments
expansion of C. difficile in mice and that C. difficile deficient in
succinate utilization pathways displayed a competitive disad-
vantage (Ferreyra et al., 2014). Moreover, the addition of succi-
nate during in vitro culture of EHEC resulted in an increase in
the expression of the LEE-encoded protein EspA in WT EHEC,
wheras the cra mutant remains unresponsive to succinate (Fig-
ure 7D). It is also worth noting that Enterococcus faecalis, whichevier Inc.
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Figure 6. Bt Contributes to the Accelerated Loss of a Protective Mucosal Layer during C. rodentium Infection
(A and B) Antibiotics-treated C3H/HeJ mice either deplete of gut microbiota or reconstituted with Bt (+Bt) were mock-infected (PBS, Bt only) or infected with
C. rodentium (Citro, Stx+), C. rodentiumDstx (CitroDstx, Stx-), or C. rodentiumDescN (CitroDescN). The histological changes in the colon and cecum were
analyzed on day 5 postinfection based on the following scoring system: edema, 0 is no edema and 5 has the highest edema in the submucosa; crypt integrity, 1 =
normal, 2 = irregular crypts, 3 =mild crypt loss, 4 = severe crypt loss, and 5 = complete crypt loss; neutrophil, neutrophilic infiltration in thewall; apoptosis, number
of apoptotic cells per 6003 field (n = five fields); bacteria attachment, bacteria associated to the epithelial surface; vasculitis, 0 is no evidence of vasculitis and 5 is
the most severe vasculitis. Scoring was performed blindly, and the scores for each parameter are an average of the cecum and distal colon, taken from two
independent experiments with three mice/experiment.
(C) Cecum harvested on day 5 postinfection was stained with Muc2 (green) and DAPI (DNA, blue). Original magnification, 103.
(D and E) qRTPCR of (D) Tff3 and (E) Muc2. RNA was isolated from colonic tissue harvested from mice on day 5 postinfection. (n = 6; error bars, SD).
(F) qRT-PCR of p1411 from feces collected on day 2 postinfection.
(G) Levels of FITC-Dextran in the serum of mice on day 5 postinfection. Mice were fasted 4 hr prior to administration of FITC-Dextran via oral gavage. FITC-
Dextran levels were determined by measuring fluorescence at excitation 490 nm, emission 525 nm (n = 6; error bars, SD; ***p < 0.001, **p < 0.01, *p < 0.05, p >
0.05 = ns).
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Gut Microbiota Increase EHEC Virulencealso increases EHEC virulence gene expression (Figure 3), also
produces and secretes copious amounts of succinate (Milstien
and Goldman, 1973).
Interestingly, Bt colonization increases the levels of g-L- glu-
tamyl-L-cysteinyl-glycine, or glutathione (GSH), and its precur-
sors cysteine and S-adenosyl-homocysteine (Figure 7A). GSH
plays a role in nutrient metabolism, antioxidant defense, and a
number of key cellular metabolic functions (Aquilano et al.,
2014). Additionally, Bt colonization alone increases the gluco-
neogenic metabolites succinate, glycerate, and lactate, creating
a different metabolic landscape for C. rodentium than what the
pathogen encounters in the microflora-deplete animals. In the
C. rodentium-infected animals deplete of a microflora, the levelsCell Host &of nucleosides (cytidine, guanosine, thymidine, and uridine) are
decreased compared to mock-infected animals. The presence
of Bt in C. rodentium-infected animals rescues this decrease
in nucleosides and nucleic acid precursors (Figure 7A). Our
findings begin to delve into the specific metabolites that a key
constituent of the microbiota, Bt, contributes to the intestinal
environment, and we link this metabolic environment to an in-
crease in virulence of an enteric pathogen.
DISCUSSION
The interaction between a host and its gastrointestinal microflora
is a delicate balance and if disturbed can result in dysbiosis (SporMicrobe 16, 759–769, December 10, 2014 ª2014 Elsevier Inc. 765
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Figure 7. Comparison of Metabolic Profiles of Bt-Reconstituted and Microflora-Deplete Animals
(A) The expression profiling of metabolites present in the cecum on day 2 postinfection (n = 5). The data are presented as ratios to show fold-changes of the
specified metabolite in the individual groups.
(B) The normalized data were analyzed by principal component analysis (PCA) with unit variance scaling in order to obtain an unbiased overview of the data and to
visualize clustering, trends, and outlier metabolites among all groups on the score plots. PCA score plots showed clear separation among the four groups in
different colors (yellow: PBS, red: Citro+Bt, blue: Citro, green: Bt) with no outliers detected. The amount of variance in the X matrix explained by PC1 (R2) was
0.732, and estimate of the predictive ability of the model (Q2) (cumulative) was 0.446.
(C) Absolute levels of succinate, fumarate, and pyruvate present in the cecum on day 2 postinfection. (A.U. Absolute Units; n = 5; error bars, SD; **p < 0.01, *p <
0.05).
(D) Protein level of the T3SS translocon protein EspA, encoded within LEE4, secreted into the supernatant of WT or Dcra EHEC cultures grown in the presence of
0.1% glucose, plus increasing levels of succinate. RpoA protein levels in the cell lysate serve as the loading control.
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Gut Microbiota Increase EHEC Virulenceet al., 2011). Host balance with the microbiota is maintained in
part through the C-type lectins RegIIIb and RegIIIg that limit
direct interaction of the microbiota with the intestinal microbiota
(Cash et al., 2006; Vaishnava et al., 2011) and in part through
maintenance of the integrity of the intestinal epithelium. Intestinal
TFF3 secreted by goblet cells plays an essential role in epithelial
repair and restoration of the mucosa (Taupin and Podolsky,
2003). Some pathogens, however, evade these host defenses
and can even benefit from them. Salmonella typhimurium thrives
in an inflammatory environment due to the production of RegIIIb
that eliminates competing microbiota (Stelter et al., 2011). In
hosts with a high-fiber diet, butyrate—a beneficial metabolite766 Cell Host & Microbe 16, 759–769, December 10, 2014 ª2014 Elsin colonic health—enhances the expression of the Stx receptor
globotriaosylceramide (Gb3) and increases susceptibility to
EHECO157:H7 infection (Zumbrun et al., 2013). Our studies indi-
cate that a normally beneficial member of the microbiota has the
capacity to enhance virulence and disease progression of an
enteric pathogen, altering themetabolic landscape toward a glu-
coneogenic environment and secreting large amounts of the
succinate metabolite within the intestine that is interpreted by
the pathogen, through the transcription factor Cra as a nutritional
cue to activate virulence gene expression. Recent findings cor-
roborate the idea that the microbiota can provide a competitive
advantage to enteric pathogens (Ng et al., 2013). Our findingsevier Inc.
Cell Host & Microbe
Gut Microbiota Increase EHEC Virulencehave fundamental implications into how the composition of the
microbiota impacts pathogen-mediated disease susceptibility
and progression and show that certain enteric pathogens
learned to exploit the microbiota to enhance their virulence.
EXPERIMENTAL PROCEDURES
Strains and Culture Conditions
Strains used in this study are listed in Table S1. B. thetaiotaomicron VPI-5482
was grown anaerobically overnight at 37C in TYGmedium (Betian et al., 1977)
plus 200 mg/ml gentamicin. WT EHECO157:H7 strain 86-24 (Griffin et al., 1988)
and its isogenic mutants (DqseC, DqseE, Dcra, DkdpE, DcraDkdpE, and
DfusK) were grown anaerobically overnight at 37C in LB plus 50 mg/ml strep-
tomycin. C. rodentium strains DBS770 (lstx2 dact) and its isogenic mutant
MMC01 (CRDescN) were grown anaerobically overnight in LB plus 25 mg/ml
chloramphenicol. The lysogenized, Stx-deficient C. rodentium strain
DBS771 was grown in LB plus 50 mg/ml kanamycin (Mallick et al., 2012). Bt
overnight culture was pelleted and concentrated 10-fold in LB. Bt was plated
in a 10-fold excess over EHEC orC. rodentium to represent the composition of
the intestinal microbiota. E. faecalis V583 (Paulsen et al., 2003) was grown
anaerobically in LB overnight, and the overnight culture was plated at a 1:1
with EHEC. The bacteria were grown anaerobically in Petri dishes in 25 ml of
prereduced low-glucose Dulbecco’s modified Eagle’s medium (DMEM) (Invi-
trogen) for 6 hr, unless otherwise noted, in a GasPak EZ anaerobe container
(Becton Dickinson). RNA was extracted using a RiboPure Bacteria RNA isola-
tion kit (Ambion) according to manufacturer’s guidelines.
Microarray Preparation and Analyses
Affymetrix 2.0 E. coli gene arrays were used to compare gene expression in
strain 86-24when cultured alone to that in strain 86-24when grown in the pres-
ence of Bt, grown anaerobically in prereduced DMEM at 37C for 6 hr to late-
log phase in a GasPak EZ anaerobe container. The relative abundance of
EHEC to Bt at the time of RNA harvest was 70% EHEC and 30% Bt. Bt grown
alone was included as a control to ensure that Bt cDNA did not hybridize to the
E. coli gene array. The RNA processing, labeling, hybridization, and slide-
scanning procedures were performed as described in the Affymetrix Gene
Expression technical manual. The array data analyses were performed as
described previously (Kendall et al., 2011). Based on array data analyses,
the biological processes of the genes significantly increased R4-fold (406
genes, 297 with known functions and 109 with unknown function) or signifi-
cantly decreased R2-fold (72 genes, 58 with known functions and 14 with
unknown function) were characterized using the Universal Protein Resource
(UniProt) Knowledgebase (UniProtKB/Swiss-Prot) (http://www.uniprot.org).
Growth Curves
Bacteria were cultured as described above for 9 hr. Bacteria were serially
diluted in PBS each hour and then plated on the following agar plates: LB
agar plus 50 mg/ml streptomycin (isolation of EHEC O157:H7), LB agar plus
25 mg/ml chloramphenicol (isolation of C. rodentium), or Brain Heart Infusion
(BHI) agar (VWR) plus 10% calf blood (Colorado Serum Company) plus
200 mg/ml gentamicin (isolation ofBt). EHECO157:H7 andC. rodentium plates
were grown aerobically at 37C for 24 hr.Bt plates were grown anaerobically at
37C for 48 hr. In each experiment, bacteria were grown on both selection
plates to confirm that growth was selective. To determine the growth rate,
two points from the exponential phase were selected (t = 2 hr, t = 5 hr) and
calculated using the formula: k = log10[Xt]log10[X0], where Xt = higher cfu/
ml, X0 = lower cfu/ml, and 0.301 3 t = time interval (in hours) between the
points. Generation time was then calculated as tgen = 1/k.
Real-Time qPCR
For in vitro experiments, cultures were grown to late-log phase in prereduced
DMEM under anaerobic conditions (6 hr). For in vivo experiments, fecal pellets
were collected from infected mice on days 0, 1, and 4 afterC. rodentium infec-
tion. RNA was extracted using the RiboPure Bacteria isolation kit according to
the manufacturer’s protocols (Ambion). To assess host gene expression, tis-
sue from the distal colon of infectedmicewas harvested on day 5 postinfection
and homogenized in 1 ml TRIzol (Life Technologies) per 100 mg tissue. RNACell Host &was isolated using standard molecular biological procedures. The primers
used for quantitative reverse transcription-PCR (qRT-PCR) (Table S2) were
validated for amplification efficiency and template specificity. qRT-PCR was
performed as previously described (Hughes et al., 2009) in a one-step reaction
using an ABI 7500 sequence detection system (Applied Biosystems). Data
were collected using the ABI Sequence Detection 1.2 software (Applied
Biosystems).
All data were normalized to an endogenous control (rpoA for virulence gene
expression in EHEC and C. rodentium, Eubacteria 16S rRNA for total bacteria
present in feces, or GAPDH for murine host gene expression in colonic tissue)
and analyzed using the comparative critical threshold (CT) method. Virulence
gene expression was presented as fold changes over the expression level of
WT EHEC or C. rodentium cultured alone in vitro or C. rodentium (DBS770)
infected alone in vivo. Host gene expression was presented as fold changes
over the expression level present in mock-infected (PBS) mice.
The relative abundances of Bacteroidetes, Firmicutes, and Proteobacteria
(familyEnterobacteriaceae) weremeasuredby qPCRwith taxon-specific or uni-
versal 16S rRNA gene primers. The primers used were as follows: Eubacteria
(universal bacteria), Eub338F, 50- actcctacgggaggcagcagt-30, and Eub338R,
50- attaccgcggctgctggc-30; Firmicutes, 928F-Firm, 50-tgaaactyaaaggaattg
acg-30, and 1040FirmR, 50-accatgcaccacctgtc-30 (Bacchetti De Gregoris
et al., 2011); Bacteroidetes, 798cfbF, 50- craacaggattagataccct-30, and cfb
967R, 50- ggtaaggttcctcgcgtat-30 (Guo et al., 2008); and g-Proteobacteria,
1080 gF, 50- tcgtcagctcgtgtygtga-30, and g1202R, 50- cgtaagggccatgatg-30
(Bacchetti De Gregoris et al., 2011). Expression of each taxon was normalized
to Eub388 and then compared to the expression level present in mock-infected
(PBS) fecal pellets on day 0 (D0). Percentage of taxa was determined by
dividing the expression of the taxon-specific 16S rRNA over the combined
expression of Firmicutes, Bacteroidetes, and g-Proteobacteria. The Student’s
unpaired t test was used to determine statistical significance.
Fluorescein Actin Staining
Fluorescein actin staining assays were performed as described by Knutton
et al. (1989). Briefly, HeLa cells were grown on coverslips in 12-well culture
plates with DMEM supplemented with 10% fetal bovine serum (FBS) and
1% penicillin/streptomycin/gentamicin antibiotic mix at 37C, 5% CO2, over-
night to 80% confluency. The wells were washed with PBS and replaced
with low-glucose DMEM supplemented with 10% FBS. Bacterial cultures
were grown anaerobically overnight as described above at 37C, and over-
night Bt culture was concentrated 10-fold in LB. Overnight bacterial cultures
were diluted 1:100 to infect confluent monolayers of HeLa cells for 6 hr at
37C, 5% CO2. After a 6 hr infection, the coverslips were washed, fixed, per-
meabilized, and treated with fluorescein isothiocyanate (FITC)-labeled phalloi-
din to visualize actin accumulation and propidium iodide to visualize host
nuclei and bacteria. The coverslips were mounted on slides and visualized
with a Zeiss Axiovert microscope. To determine percentage infected cells,
five to seven fields from three separate coverslips (triplicate) were counted
and calculated as (Cells with Pedestals/Total cells),100. Statistical analyses
were performed using the Student’s unpaired t test.
Mice
C3H/HeJ mice were purchased from The Jackson Laboratory and housed in a
specific pathogen-free facility at UT Southwestern Medical Center. All exper-
iments were performed under IACUC approved protocols.
At 3 to 4weeks of age, female C3H/HeJmicewere orally administered a com-
bination of four antibiotics: ampicillin, neomycin, metronidazole, and vancomy-
cin (Sigma-Aldrich) via oral gavage for 5 or 6 days to deplete gut microbiota
(5 mg of each antibiotic per mouse per day) (Rakoff-Nahoum et al., 2004). Fecal
pelletswere collectedbefore and after antibiotics treatment to confirmdepletion
of the gutmicrobiota. Feces were resuspended in PBS at 1 g/ml, serially diluted,
and plated on BHI-Blood agar plates containing no antibiotics. Colony counts
were performedafter 48 hr incubation at 37Cunder both aerobic and anaerobic
conditions. Following antibiotics treatment, half of the mice were reconstituted
with 33 109 colony-forming units (cfu)Bt via oral gavage while the remainder of
the mice were left deplete of gut microbiota. Twenty hours later, mice were
mock infected with PBS or orally infected with 1 3 109 cfu C. rodentium
(DBS770, Stx+), C. rodentiumDstx (DBS771, Stx-), C. rodentiumDescN
(MMC01, CitroDescN), or C. rodentiumDcra (MMC02, CitroDcra).Microbe 16, 759–769, December 10, 2014 ª2014 Elsevier Inc. 767
Cell Host & Microbe
Gut Microbiota Increase EHEC VirulenceBaseline weight of mice was measured on the initial day of C. rodentium
infection (D0). Mice were weighed daily for the course of infection. Percentage
weight was calculated in the following way: [(WeightDay n – Baseline weight)/
Baseline weight],100. Change in weight reflects weight gain or weight loss
over the course of infection. Mice were monitored daily for survival. The exper-
iments were performed at least twice with a total of 7–22 mice per group.
Weight change and survival curves reflect the average of experiments plus
the SD. The Student’s unpaired t test was used to determine the statistical sig-
nificance of each day on the survival curve.
To measure gut permeability, mice were fasted for 4 hr prior to administra-
tion of 20 ml/kg of FITC-dextran (Sigma) via oral gavage on day 5 postinfec-
tion with C. rodentium. Fasting conditions were maintained for an additional
3 hr, at which point blood was collected and centrifuged to collect plasma.
Serum was diluted 1:2 in PBS and fluorescence at excitation 490 nm, emis-
sion 520 nm, was measured using a fluorimeter. A standard curve was pre-
pared by serially diluting FITC-dextran in a consistent PBS:mouse serum
with the samples.
Histopathology
Portions of the distal colon and cecum were harvested 5 days postinfection
with C. rodentium. The tissues were washed in PBS and then fixed in Bouin’s
fixative for 48 hr. The tissues were embedded in paraffin, cut into 5-mm sec-
tions, and stained with hematoxylin and eosin in the UT Southwestern Pathol-
ogy Core. Histological changes were analyzed in a double-blind fashion. The
severity of intestinal pathology was analyzed based on the following scoring
system: edema, 0 is no edema and 5 has the highest edema in the submucosa;
crypt integrity, 1 = normal, 2 = irregular crypts, 3 = mild crypt loss, 4 = severe
crypt loss, and 5 = complete crypt loss; neutrophil, neutrophilic infiltration in
the wall; apoptosis, number of apoptotic cells per 600 3 field (n = five fields);
bacteria attachment, bacteria associated to the epithelial surface; goblet cell,
average number of goblet cell in each crypt (n > 10 crypts); and vasculitis, 0 is
no evidence of vasculitis and 5 is the most severe vasculitis. The scores for
each parameter are an average of the cecum and distal colon, taken from
two independent experiments with three mice/experiment.
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